511 Therapeutics, Inc. funding

511 Therapeutics, Inc., a biotechnology company based in Cambridge, MA (founded 2022), filed a Form D with the SEC on October 30, 2026 and reported $500K raised of a $1M offering.

Amount raised$500K

Offering size$1M

Filed with the SECOctober 30, 2026

First saleOctober 21, 2026

IndustryBiotechnology

SecuritiesOptions or warrants

LocationCambridge, MA

Founded2022

Entity typeCorporation

Investors so far1

Minimum investment—

Revenue rangeDecline to Disclose

View the original Form D on SEC EDGAR ↗ · All rounds filed Oct 30

Other health care rounds in Massachusetts

Zai Lab Ltd$250M · Nov 9Biotechnology AI3 Bio, Inc.$48.3M · Nov 4Biotechnology Nanopath Inc$29.9M · Nov 13Biotechnology XRHealth, Inc.$16.3M · Oct 23Other Health Care Crosslink Therapeutics Inc.$5.5M · Oct 20Pharmaceuticals Fresenius Medical Care Fulshear, LLC$4.4M · Oct 21Other Health Care BridgeHealth Pharmaceuticals, Inc.$3.5M · Nov 5Pharmaceuticals Quiver Holdings Inc.$3M · Oct 21Biotechnology